This research report provides a comprehensive analysis of the Cancer Pain market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cancer Pain market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cancer Pain, challenges faced by the industry, and potential opportunities for market players.
The global Cancer Pain market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cancer Pain market presents opportunities for various stakeholders, including Radiotherapy, Chemotherapy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cancer Pain market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cancer Pain market was valued at US$ 5845.8 million in 2023 and is projected to reach US$ 8208.6 million by 2030, at a CAGR of 5.5% during the forecast period.
The growth of the global cancer pain market is mainly due to the increasing prevalence of cancer; rising geriatric population; rising healthcare expenditure; and increasing investment in research and development activities by various healthcare companies. Due to aging effects and genetic mutations, older people are more prone to various types of cancer, such as lung cancer, bladder cancer, kidney cancer, melanoma, etc. According to the National Cancer Institute, the median age at diagnosis is 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer and 66 for prostate cancer. However, side effects associated with drugs used in cancer pain treatment, such as drug tolerance, drug dependence, urinary retention, sleep disturbance, cognitive impairment, etc., are expected to restrain the growth of the cancer pain market over the forecast period.
Key Features:
The research report on the Cancer Pain market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cancer Pain market.
Market Overview: The report provides a comprehensive overview of the Cancer Pain market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Opioids, Non-Steroidal Anti-Inflammatory Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cancer Pain market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cancer Pain market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cancer Pain market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cancer Pain market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cancer Pain market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cancer Pain market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cancer Pain, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cancer Pain market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cancer Pain market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Market segment by Application
Radiotherapy
Chemotherapy
Hormone Therapy
Others
Global Cancer Pain Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson?Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Pain, market overview.
Chapter 2: Global Cancer Pain market size in revenue.
Chapter 3: Detailed analysis of Cancer Pain company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Pain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Pain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Pain Overall Market Size
2.1 Global Cancer Pain Market Size: 2023 VS 2030
2.2 Global Cancer Pain Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Pain Players in Global Market
3.2 Top Global Cancer Pain Companies Ranked by Revenue
3.3 Global Cancer Pain Revenue by Companies
3.4 Top 3 and Top 5 Cancer Pain Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cancer Pain Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Pain Players in Global Market
3.6.1 List of Global Tier 1 Cancer Pain Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Pain Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Pain Market Size Markets, 2023 & 2030
4.1.2 Opioids
4.1.3 Non-Steroidal Anti-Inflammatory Drugs
4.1.4 Others
4.2 By Type - Global Cancer Pain Revenue & Forecasts
4.2.1 By Type - Global Cancer Pain Revenue, 2019-2024
4.2.2 By Type - Global Cancer Pain Revenue, 2025-2030
4.2.3 By Type - Global Cancer Pain Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Pain Market Size, 2023 & 2030
5.1.2 Radiotherapy
5.1.3 Chemotherapy
5.1.4 Hormone Therapy
5.1.5 Others
5.2 By Application - Global Cancer Pain Revenue & Forecasts
5.2.1 By Application - Global Cancer Pain Revenue, 2019-2024
5.2.2 By Application - Global Cancer Pain Revenue, 2025-2030
5.2.3 By Application - Global Cancer Pain Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer Pain Market Size, 2023 & 2030
6.2 By Region - Global Cancer Pain Revenue & Forecasts
6.2.1 By Region - Global Cancer Pain Revenue, 2019-2024
6.2.2 By Region - Global Cancer Pain Revenue, 2025-2030
6.2.3 By Region - Global Cancer Pain Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cancer Pain Revenue, 2019-2030
6.3.2 US Cancer Pain Market Size, 2019-2030
6.3.3 Canada Cancer Pain Market Size, 2019-2030
6.3.4 Mexico Cancer Pain Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Pain Revenue, 2019-2030
6.4.2 Germany Cancer Pain Market Size, 2019-2030
6.4.3 France Cancer Pain Market Size, 2019-2030
6.4.4 U.K. Cancer Pain Market Size, 2019-2030
6.4.5 Italy Cancer Pain Market Size, 2019-2030
6.4.6 Russia Cancer Pain Market Size, 2019-2030
6.4.7 Nordic Countries Cancer Pain Market Size, 2019-2030
6.4.8 Benelux Cancer Pain Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Pain Revenue, 2019-2030
6.5.2 China Cancer Pain Market Size, 2019-2030
6.5.3 Japan Cancer Pain Market Size, 2019-2030
6.5.4 South Korea Cancer Pain Market Size, 2019-2030
6.5.5 Southeast Asia Cancer Pain Market Size, 2019-2030
6.5.6 India Cancer Pain Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cancer Pain Revenue, 2019-2030
6.6.2 Brazil Cancer Pain Market Size, 2019-2030
6.6.3 Argentina Cancer Pain Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Pain Revenue, 2019-2030
6.7.2 Turkey Cancer Pain Market Size, 2019-2030
6.7.3 Israel Cancer Pain Market Size, 2019-2030
6.7.4 Saudi Arabia Cancer Pain Market Size, 2019-2030
6.7.5 UAE Cancer Pain Market Size, 2019-2030
7 Cancer Pain Companies Profiles
7.1 BioDelivery Science
7.1.1 BioDelivery Science Company Summary
7.1.2 BioDelivery Science Business Overview
7.1.3 BioDelivery Science Cancer Pain Major Product Offerings
7.1.4 BioDelivery Science Cancer Pain Revenue in Global Market (2019-2024)
7.1.5 BioDelivery Science Key News & Latest Developments
7.2 ProStrakan Group
7.2.1 ProStrakan Group Company Summary
7.2.2 ProStrakan Group Business Overview
7.2.3 ProStrakan Group Cancer Pain Major Product Offerings
7.2.4 ProStrakan Group Cancer Pain Revenue in Global Market (2019-2024)
7.2.5 ProStrakan Group Key News & Latest Developments
7.3 Teva pharmaceuticals
7.3.1 Teva pharmaceuticals Company Summary
7.3.2 Teva pharmaceuticals Business Overview
7.3.3 Teva pharmaceuticals Cancer Pain Major Product Offerings
7.3.4 Teva pharmaceuticals Cancer Pain Revenue in Global Market (2019-2024)
7.3.5 Teva pharmaceuticals Key News & Latest Developments
7.4 Eli-Lilly
7.4.1 Eli-Lilly Company Summary
7.4.2 Eli-Lilly Business Overview
7.4.3 Eli-Lilly Cancer Pain Major Product Offerings
7.4.4 Eli-Lilly Cancer Pain Revenue in Global Market (2019-2024)
7.4.5 Eli-Lilly Key News & Latest Developments
7.5 Grunenthal Group
7.5.1 Grunenthal Group Company Summary
7.5.2 Grunenthal Group Business Overview
7.5.3 Grunenthal Group Cancer Pain Major Product Offerings
7.5.4 Grunenthal Group Cancer Pain Revenue in Global Market (2019-2024)
7.5.5 Grunenthal Group Key News & Latest Developments
7.6 GW Pharmaceuticals
7.6.1 GW Pharmaceuticals Company Summary
7.6.2 GW Pharmaceuticals Business Overview
7.6.3 GW Pharmaceuticals Cancer Pain Major Product Offerings
7.6.4 GW Pharmaceuticals Cancer Pain Revenue in Global Market (2019-2024)
7.6.5 GW Pharmaceuticals Key News & Latest Developments
7.7 Johnson?Johnson
7.7.1 Johnson?Johnson Company Summary
7.7.2 Johnson?Johnson Business Overview
7.7.3 Johnson?Johnson Cancer Pain Major Product Offerings
7.7.4 Johnson?Johnson Cancer Pain Revenue in Global Market (2019-2024)
7.7.5 Johnson?Johnson Key News & Latest Developments
7.8 Meda Pharmaceuticals
7.8.1 Meda Pharmaceuticals Company Summary
7.8.2 Meda Pharmaceuticals Business Overview
7.8.3 Meda Pharmaceuticals Cancer Pain Major Product Offerings
7.8.4 Meda Pharmaceuticals Cancer Pain Revenue in Global Market (2019-2024)
7.8.5 Meda Pharmaceuticals Key News & Latest Developments
7.9 Orexo
7.9.1 Orexo Company Summary
7.9.2 Orexo Business Overview
7.9.3 Orexo Cancer Pain Major Product Offerings
7.9.4 Orexo Cancer Pain Revenue in Global Market (2019-2024)
7.9.5 Orexo Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Cancer Pain Major Product Offerings
7.10.4 Sanofi Cancer Pain Revenue in Global Market (2019-2024)
7.10.5 Sanofi Key News & Latest Developments
7.11 WEX Pharmaceuticals
7.11.1 WEX Pharmaceuticals Company Summary
7.11.2 WEX Pharmaceuticals Business Overview
7.11.3 WEX Pharmaceuticals Cancer Pain Major Product Offerings
7.11.4 WEX Pharmaceuticals Cancer Pain Revenue in Global Market (2019-2024)
7.11.5 WEX Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Pain Market Opportunities & Trends in Global Market
Table 2. Cancer Pain Market Drivers in Global Market
Table 3. Cancer Pain Market Restraints in Global Market
Table 4. Key Players of Cancer Pain in Global Market
Table 5. Top Cancer Pain Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cancer Pain Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cancer Pain Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cancer Pain Product Type
Table 9. List of Global Tier 1 Cancer Pain Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Pain Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cancer Pain Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cancer Pain Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cancer Pain Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cancer Pain Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cancer Pain Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cancer Pain Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cancer Pain Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cancer Pain Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cancer Pain Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cancer Pain Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cancer Pain Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cancer Pain Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cancer Pain Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cancer Pain Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cancer Pain Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cancer Pain Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cancer Pain Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cancer Pain Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cancer Pain Revenue, (US$, Mn), 2025-2030
Table 30. BioDelivery Science Company Summary
Table 31. BioDelivery Science Cancer Pain Product Offerings
Table 32. BioDelivery Science Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 33. BioDelivery Science Key News & Latest Developments
Table 34. ProStrakan Group Company Summary
Table 35. ProStrakan Group Cancer Pain Product Offerings
Table 36. ProStrakan Group Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 37. ProStrakan Group Key News & Latest Developments
Table 38. Teva pharmaceuticals Company Summary
Table 39. Teva pharmaceuticals Cancer Pain Product Offerings
Table 40. Teva pharmaceuticals Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 41. Teva pharmaceuticals Key News & Latest Developments
Table 42. Eli-Lilly Company Summary
Table 43. Eli-Lilly Cancer Pain Product Offerings
Table 44. Eli-Lilly Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 45. Eli-Lilly Key News & Latest Developments
Table 46. Grunenthal Group Company Summary
Table 47. Grunenthal Group Cancer Pain Product Offerings
Table 48. Grunenthal Group Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 49. Grunenthal Group Key News & Latest Developments
Table 50. GW Pharmaceuticals Company Summary
Table 51. GW Pharmaceuticals Cancer Pain Product Offerings
Table 52. GW Pharmaceuticals Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 53. GW Pharmaceuticals Key News & Latest Developments
Table 54. Johnson?Johnson Company Summary
Table 55. Johnson?Johnson Cancer Pain Product Offerings
Table 56. Johnson?Johnson Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 57. Johnson?Johnson Key News & Latest Developments
Table 58. Meda Pharmaceuticals Company Summary
Table 59. Meda Pharmaceuticals Cancer Pain Product Offerings
Table 60. Meda Pharmaceuticals Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 61. Meda Pharmaceuticals Key News & Latest Developments
Table 62. Orexo Company Summary
Table 63. Orexo Cancer Pain Product Offerings
Table 64. Orexo Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 65. Orexo Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Cancer Pain Product Offerings
Table 68. Sanofi Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 69. Sanofi Key News & Latest Developments
Table 70. WEX Pharmaceuticals Company Summary
Table 71. WEX Pharmaceuticals Cancer Pain Product Offerings
Table 72. WEX Pharmaceuticals Cancer Pain Revenue (US$, Mn) & (2019-2024)
Table 73. WEX Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Cancer Pain Segment by Type in 2023
Figure 2. Cancer Pain Segment by Application in 2023
Figure 3. Global Cancer Pain Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cancer Pain Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cancer Pain Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Pain Revenue in 2023
Figure 8. By Type - Global Cancer Pain Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cancer Pain Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cancer Pain Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cancer Pain Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cancer Pain Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cancer Pain Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cancer Pain Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cancer Pain Revenue Market Share, 2019-2030
Figure 16. US Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cancer Pain Revenue Market Share, 2019-2030
Figure 20. Germany Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 21. France Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cancer Pain Revenue Market Share, 2019-2030
Figure 28. China Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 32. India Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cancer Pain Revenue Market Share, 2019-2030
Figure 34. Brazil Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cancer Pain Revenue Market Share, 2019-2030
Figure 37. Turkey Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cancer Pain Revenue, (US$, Mn), 2019-2030
Figure 41. BioDelivery Science Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. ProStrakan Group Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Teva pharmaceuticals Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Eli-Lilly Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Grunenthal Group Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. GW Pharmaceuticals Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Johnson?Johnson Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Meda Pharmaceuticals Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Orexo Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Sanofi Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. WEX Pharmaceuticals Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
